This inventor holds 1 USPTO granted patent. Top assignee: James Black Foundation Limited. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: John Spencer: Innovator in Gastrin and Cholecystokinin Receptor Ligands
Introduction
John Spencer is a notable inventor based in London, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with gastrin and cholecystokinin receptors. His work has implications for various therapeutic applications.
Latest Patents
John Spencer holds a patent for "Pyrazole derivatives and their use as gastrin and cholecystokinin receptor ligands." This patent describes compounds of formula (I), (IIa), or (IIb), wherein R-R, Z, Q, and n are defined in the claims. These compounds, along with their pharmaceutically acceptable salts, serve as ligands at gastrin and/or cholecystokinin receptors. The patent also details compositions that include these innovative compounds.
Career Highlights
John Spencer is associated with the James Black Foundation Limited, where he continues to advance research in his field. His work is characterized by a commitment to exploring new therapeutic avenues through innovative chemical compounds.
Collaborations
Some of his notable coworkers include Iain Mair McDonald and Caroline Minli Rachel Low. Their collaborative efforts contribute to the ongoing research and development in the area of receptor ligands.
Conclusion
John Spencer's contributions to the field of medicinal chemistry, particularly through his patent on pyrazole derivatives, highlight his role as an innovator. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile